Lucid Diagnostics Inc. — Director's Dealing 2025

Feb 21, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2025-02-20

Reporting Person: MCGRATH DENNIS M (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-20	Common stock	A	300000	—	Acquired	1343569	Direct

Footnotes

F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

F2: Includes 19,169 shares of Lucid common stock distributed by PAVmed on February 15, 2024 to Mr. McGrath, representing his share of the shares of Lucid common stock distributed by PAVmed to its shareholders on a pro rata basis on such date.